Clinical Trials for Cara Therapeutics

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Cara Therapeutics

Clinical Trials (3)

NCT06788990
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
PHASE2/PHASE3Recruiting
650 participants
Started: Jan 28, 2025 · Completed: Jul 31, 2029
2 conditions1 sponsor52 locations
NCT05762107
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
PHASE2Recruiting
186 participants
Started: Jul 28, 2023 · Completed: Jul 31, 2025
1 condition1 sponsor25 locations
NCT04429542
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
PHASE1Recruiting
292 participants
Started: Jun 1, 2020 · Completed: Jun 1, 2027
11 conditions2 sponsors20 locations